Insider Trading July 2, 2026 09:16 PM

CoreWeave CFO Nitin Agrawal Disposes of Shares Amid Company Valuation Shifts

Insider transaction records show executive stock sales for tax obligations, concurrent with broader market volatility and analyst revisions.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
CRWV

CoreWeave, Inc. (NASDAQ:CRWV) Chief Financial Officer Nitin Agrawal executed a transaction on June 30, 2026, selling four shares of the company's Class A Common Stock. The sale, valued at $382, was conducted to meet tax withholding requirements related to the vesting and settlement of restricted stock units. This transaction occurred as CoreWeave's stock price experienced a decline of over 15% in a single week, dropping to $81.75. The insider activity takes place against a backdrop of financial analysis highlighting the company's cash burn and debt levels, alongside recent analyst updates and product launches.

CoreWeave CFO Nitin Agrawal Disposes of Shares Amid Company Valuation Shifts
CRWV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CoreWeave CFO Nitin Agrawal sold 4 shares for $382 to cover tax obligations from restricted stock unit settlements, while simultaneously acquiring 7 additional shares at $0.00 from the same vesting events.
  • The company's stock price has declined over 15% in a single week, falling to $81.75, amidst reports of significant cash burn and a substantial debt burden.
  • Analyst ratings remain positive with Rosenblatt at $250 and Evercore ISI at $150, despite a recent stock decline triggered by Meta Platforms' potential entry into the AI cloud infrastructure market.

CoreWeave, Inc. (NASDAQ:CRWV) Chief Financial Officer Nitin Agrawal executed a transaction on June 30, 2026, selling four shares of the company's Class A Common Stock. The sale, valued at $382, was conducted to meet tax withholding requirements related to the vesting and settlement of restricted stock units. This transaction occurred as CoreWeave's stock price experienced a decline of over 15% in a single week, dropping to $81.75. The insider activity takes place against a backdrop of financial analysis highlighting the company's cash burn and debt levels, alongside recent analyst updates and product launches.

On the same day, Mr. Agrawal also acquired 7 shares of Class A Common Stock at a price of $0.0, which stemmed from the vesting and settlement of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of CoreWeave’s Class A Common Stock upon settlement. The timing of these insider transactions comes as InvestingPro data reveals CoreWeave is quickly burning through cash and operates with a significant debt burden—two of 15 exclusive ProTips available to subscribers analyzing the company’s financial health.

Following these transactions, Mr. Agrawal directly holds 193,774 shares of Class A Common Stock. His indirect holdings include 34,905 shares held by his spouse, 81,000 shares held by the Yellowstone 2025 GRAT (of which his spouse is the beneficiary and he serves as trustee), and 57,952 shares held by the Yosemite 2025 GRAT (for which he is the sole trustee and beneficiary).

Mr. Agrawal also holds 83 Restricted Stock Units. These units were granted subject to a performance-based vesting condition, which was satisfied in connection with the company’s initial public offering, and a service-based vesting schedule. The award vests as to one-quarter of the total award on March 31, 2026, and thereafter vests as to one-sixteenth of the total award on the last calendar day of June, September, December, and March, contingent on Mr. Agrawal’s continued service to CoreWeave on each vesting date. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

In other recent news, CoreWeave has been the subject of multiple developments. Rosenblatt reiterated its Buy rating and set a price target of $250 for CoreWeave, following reports that Meta Platforms is considering launching a cloud business to sell AI computing power. Similarly, Evercore ISI maintained an Outperform rating with a $150 price target, even as Meta’s plans for a cloud infrastructure business were unveiled. This announcement led to a decline in CoreWeave shares, reflecting investor reactions to potential competition from Meta.

Additionally, CoreWeave has launched a preview of ARIA, an AI research agent designed to analyze experiment data using their W&B Weave platform. The tool aims to support model and agent development by generating reports and visualizations. Evercore ISI also updated its financial model for CoreWeave, revising its earnings estimates due to changes in tax accounting and interest expense timing. The updated earnings per share estimates for CY26 and CY27 stand at negative $5.12 and negative $4.30, respectively.

Risks

  • CoreWeave is facing a high cash burn rate and carries a significant debt burden, which may pressure its financial health and operational flexibility.
  • The company faces potential competitive threats from Meta Platforms, which is reportedly considering launching a cloud business to sell AI computing power, potentially impacting CoreWeave's market position.
  • Financial projections indicate negative earnings per share for CY26 at negative $5.12 and CY27 at negative $4.30, reflecting underlying profitability challenges.

More from Insider Trading

Spyre Therapeutics CFO Executes Pre-Arranged Share Sales Amid Clinical Momentum Jul 2, 2026 Lightspeed Affiliates Divest $260K in Navan Shares Amid Post-IPO Restructuring Jul 2, 2026 Lightspeed Management Exits Navan Position; Company Pursues Strategic Acquisitions and AI Integrations Jul 2, 2026 Spyre Therapeutics CMO Sheldon Sloan Liquidates Holdings Following $730K Sale Jul 2, 2026 Spyre Therapeutics CEO Cameron Turtle Sells $1.32M in Shares Amid Pipeline Progress Jul 2, 2026